CLINICAL_TRIALS
trial_result
· 2023-12-01
Clinical Trial Update: A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer [Phase 2]
Summary
Phase II open-label study of BMS-582664 in locally advanced or metastatic hepatocellular carcinoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01